Navigation Links
Congestion for Use of Clarinex-D 12 Hour cleared – FDA Gives the No

The FDA has given its consent for the novel version of the allergy medicine, Clarinex-D 12 Hour, to alleviate nasal, non nasal symptoms and nasal congestion occurring in adults and children above the age of 12. According to the // researchers, this medicine will be in time for the spring allergy season.

It is estimated that about 36 million people in the U.S. are troubled by seasonal allergies with apparent runny nose, sneezing, nasal congestion, and itchy, watery eyes, symptoms.

Clarinex (desloratadine) , used for treatment of seasonal allergy symptoms, is a nonsedating antihistamine procured only by prescription . Approval for Clarinex-D 24 Hour (containing 5 milligrams desloratadine and 240 milligrams pseudo ephedrine), prescribed only once a day was obtained last spring. Clarinex-D 12 hour, the recently approved medicine contains 2.5 milligrams desloratadine and 120 milligrams pseudo ephedrine, and can be consumed twice a day.

The FDA approval was close on the heels of two clinical trials involving 1,200 people or more who suffered seasonal allergies. The trails involved comparison of the treatment with Clarinex-D 12 HOUR extended-release tablets with pseudoephedrine alone and desloratadine alone. The results depicted that the extended-release-combined medication eased nasal congestion as well as provided immense relief compared to desloratadine alone, relieving other allergy symptoms better than pseudoephedrine alone.

Insomnia, headache, dry mouth, and fatigue are some of the common side effects associated with Clarinex-D 12 Hour use. This medicine should not be taken by those suffering from narrow-angle glaucoma, severe high blood pressure or heart disease, urination difficulty, or by patients who may have taken a monoamine-oxidase inhibitor 14 days prior to the use of this drug. It also recommended that those with certain other medical conditions such as high blood pressure, diabetes, heart disease, thyroid, liver , or kidney problems, or enlarged prostate should seek the advice of a medical specialist before resorting to the use of Clarinex-D 12 hour or Clarinex-D 24 Hour.


'"/>




Related medicine news :

1. British Doctor cleared of murder
2. Mist over a way to help premature babies breathes cleared!
3. Business model for Liver Institute cleared by Delhi Cabinet
4. Groundbreaking Study Gives Hope For Patients With Kidney Cancer
5. Gene Therapy Gives Hope For Patients With Muscular Dystrophy
6. Statins Gives New Hope for Increased Survival Rate of Heart Failure Patients
7. US Doctors Association Gives away $110,000 To NGO’
8. Woman In Coma Gives Birth To Daughter
9. Artificial Heart , Gives Hope For Patients Awaiting a Heart Transplant
10. New Eye Surgery Gives Hope To Short-Sighted
11. Jharkhand Gives Health industry status
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... TX (PRWEB) , ... October 13, 2017 , ... ... planning agency serving communities in the greater Dallas, Miami, and Raleigh regions, is ... boy fighting to overcome a rare and deadly chromosome abnormality. , After struggling ...
(Date:10/13/2017)... ... 2017 , ... The American Board of Family Medicine's (ABFM) Board of Directors ... Officer, succeeding Dr. James C. Puffer upon his retirement. Dr. Newton will serve in ... retirement at the end of 2018. Upon assuming the role of President and CEO ...
(Date:10/13/2017)... ... 2017 , ... Lori R. Somekh, founder of the Law Office of ... elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office remain ... to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading network ... advocate for action towards gender equality at their inaugural Summit in New York City ... and reached a social audience of over 3 million. To watch the Mobilize Women ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
Breaking Medicine News(10 mins):
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2017 Halo Labs announces the European launch of their ... HORIZON at MIBio 2017 in Cambridge, U.K ... matter in biopharmaceutical samples with unprecedented speed and sensitivity while using ... Backgrounded Membrane Imaging. ... subvisible particle analysis system ...
(Date:9/27/2017)... , Sept. 27, 2017  Commended for their devotion ... notable awards. Ranked as number one in the South Florida ... time in Inc. 5000 yearly list, the national specialty pharmacy ... Armando Bardisa will soon be honored by SFBJ ... Set to receive his award in ...
Breaking Medicine Technology: